Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment
Katherine C. Kurnit, Gini F. Fleming, Ernst Lengyel
Obstetrics and Gynecology (2020) Vol. 137, Iss. 1, pp. 108-121
Open Access | Times Cited: 245

Showing 1-25 of 245 citing articles:

Deep Visual Proteomics defines single-cell identity and heterogeneity
Andreas Mund, Fabian Coscia, András Kriston, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 8, pp. 1231-1240
Open Access | Times Cited: 317
Epithelial ovarian cancer: Review article
S. Suchetha
Cancer Treatment and Research Communications (2022) Vol. 33, pp. 100629-100629
Open Access | Times Cited: 86
Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status
Yongsong Wu, Shilin Xu, Shanshan Cheng, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 38
Chronotherapy in Glioblastoma: state of the art and future perspectives
Marina Petković, Melad Henis, Oliver Heese, et al.
EBioMedicine (2023) Vol. 89, pp. 104470-104470
Open Access | Times Cited: 27
Oncogenic Pathways and Targeted Therapies in Ovarian Cancer
Carolina Lliberos, Gary Richardson, Antonella Papa
Biomolecules (2024) Vol. 14, Iss. 5, pp. 585-585
Open Access | Times Cited: 9
Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
Lucía Pascual‐Antón, Beatriz Cardeñes, Ricardo Sáinz de la Cuesta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11496-11496
Open Access | Times Cited: 54
A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing
Ernst Lengyel, Yan Li, Melanie Weigert, et al.
Cell Reports (2022) Vol. 41, Iss. 12, pp. 111838-111838
Open Access | Times Cited: 37
Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application
Alessandra Ciucci, Marianna Buttarelli, Anna Fagotti, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Open Access | Times Cited: 32
Minimally invasive injection of biomimetic Nano@Microgel for in situ ovarian cancer treatment through enhanced photodynamic reactions and photothermal combined therapy
Xiaodong Ma, Wenhui Zhou, Rong Zhang, et al.
Materials Today Bio (2023) Vol. 20, pp. 100663-100663
Open Access | Times Cited: 22
Primary and secondary tumors of the peritoneum: key imaging features and differential diagnosis with surgical and pathological correlation
Javier Gonzalez, Francesc Calaf Forn, Laura Pelegrí Martínez, et al.
Insights into Imaging (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Identifying Serum Small Extracellular Vesicle MicroRNA as a Noninvasive Diagnostic and Prognostic Biomarker for Ovarian Cancer
Lei Li, Fuchuang Zhang, Jiyang Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 19, pp. 19197-19210
Closed Access | Times Cited: 18
The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers
Majid Ghasemian, Mojtaba Zehtabi, Mahrokh Abouali Gale Dari, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Therapeutic effects and molecular mechanisms of quercetin in gynecological disorders
Xian Jian, Shi Chen, Weichen Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116418-116418
Open Access | Times Cited: 7
A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers
Gökçe Şeker Karatoprak, Berrak Altınsoy, Engin Celep, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A
Jin Wang, Lingxia Liu
Journal of Ovarian Research (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 38
Radiomics based on multisequence magnetic resonance imaging for the preoperative prediction of peritoneal metastasis in ovarian cancer
Xiaoli Song, Jialiang Ren, Ting-Yu Yao, et al.
European Radiology (2021) Vol. 31, Iss. 11, pp. 8438-8446
Closed Access | Times Cited: 33
Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer
Arnold Lee
Targeted Oncology (2021) Vol. 16, Iss. 6, pp. 839-845
Open Access | Times Cited: 33
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity
Brian C. Orr, Haider Mahdi, Yusi Fang, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 10, pp. 2038-2049
Open Access | Times Cited: 24
The Utilization of Bevacizumab in Patients with Advanced Ovarian Cancer: A Systematic Review of the Mechanisms and Effects
Chih-Lin Mao, Kok‐Min Seow, Kuo-Hu Chen
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6911-6911
Open Access | Times Cited: 24
Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer
Ping Yu, Yaru Wang, Dahai Yuan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies
Ying Wei, Sonia Erfani, David Schweer, et al.
Molecular Therapy — Oncolytics (2023) Vol. 28, pp. 293-306
Open Access | Times Cited: 14
Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Olivia G. Huffman, Danielle Chau, Andreea Dinicu, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1402-1402
Open Access | Times Cited: 14
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Qilin Zhang, Yiling Ding, Yamin Shu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models
Tao Pu, Yawei Liu, Yuetian Pei, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 27, pp. 32226-32239
Open Access | Times Cited: 13
Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects
Shahil Alam, P. Giri
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top